Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity againstPseudomonas aeruginosa
Cefiderocol (S-649266) is a novel parenteral siderophore cephalosporin conjugated with a catechol moiety at the 3rd-position side chain. Thein vitroactivity of cefiderocol againstPseudomonas aeruginosawas enhanced in the iron-depleted condition where that of ceftazidime was not affected. The monitoring of [Thiazole-14C]-cefiderocol revealed the increased intracellular accumulation of cefiderocol in theP. aeruginosacells incubated under iron-depleted condition compared with those incubated under iron-sufficient condition. Cefiderocol was shown to have potent chelating activity with ferric iron, and extracellular iron was efficiently transported intoP. aeruginosacells in the presence of cefiderocol as well as siderophores, while enhanced transport of extracellular ferric iron was not observed when one of the hydroxyl groups of catechol moiety of cefiderocol was substituted with a methoxy group. We conclude that cefiderocol forms a chelating complex with iron, which is actively transported intoP. aeruginosacells via iron transporters, resulting in potent antibacterial activity of cefiderocol againstP. aeruginosa.